Transforming the gene therapy landscape
with AI-powered AAV vectors

The Outlook

Gene therapies of the future will be designed using artificial intelligence (AI) to reach more patients and treat many more diseases.

Our Solution

Dyno Therapeutics is applying AI technology to discover novel gene therapy vectors with transformative delivery properties for a vast landscape of human diseases.


Read about our scientists' publications in Science, Nature Biotechnology, at ASGCT and more.


Dyno closes $100 million Series A financing led by Andreessen Horowitz


Dyno Therapeutics to Accelerate Design of High-Performance Biological Sequences Using NVIDIA AI

Dyno Therapeutics Unveils Path to Exponentially Reducing the Cost of In Vivo Gene Delivery at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Back to Top